Bovine rotavirus vaccine - Wuhan Institute of Biological Products

Drug Profile

Bovine rotavirus vaccine - Wuhan Institute of Biological Products

Alternative Names: BRV - Wuhan Institute of Biological Products

Latest Information Update: 14 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wuhan Institute of Biological Products
  • Class Rotavirus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Rotavirus infections

Most Recent Events

  • 04 Jul 2016 Phase-I clinical trials in Rotavirus infections (In infants, In children, In adults) in China (Parenteral) (ChiCTR-PIR-16008824)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top